
Areas of Expertise
Conditions I Treat
- Lymphoma
- Hodgkin lymphoma (Hodgkin’s disease)
- Non-Hodgkin lymphoma (NHL)
My Specialties
- Cellular therapy
Get to Know Me
A lymphoma specialist is a doctor with special training in diagnosing and treating lymphoma.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
- Assistant Attending Physician
Conditions I Treat
- Lymphoma
- Hodgkin lymphoma (Hodgkin’s disease)
- Non-Hodgkin lymphoma (NHL)
- Follicular zone lymphoma
- Mantle cell lymphoma (MCL)
- Marginal zone lymphomas
- Diffuse large b-cell lymphoma (DLBCL)
- Chronic lymphocytic leukemia (CLL)
- Small lymphocytic lymphoma (SLL)
- Burkitt lymphoma
My Specialties
- Cellular therapy
Education
- MD, University of Massachusetts Medical School
Residencies
- Internal Medicine, Brigham and Women's Hospital/Harvard Medical School
Fellowships
- Medical Oncology/Hematology, Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine (ABIM)
- Medical Oncology (ABIM)
Awards and Honors
- Merit Award, American Society of Clinical Oncology (2023)
- Young Investigator Award, American Society of Clinical Oncology Conquer Cancer Foundation (2022)
- Chief Medical Oncology and Hematology Fellow, Memorial Sloan Kettering Cancer Center (2021-2022)
- Mortimer J. Lacher Fellowship Recipient, Memorial Sloan Kettering Cancer Center (2021, 2022)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

Contact and Location
Dr. Boardman sees patients at one location.






Looking to see a doctor at a different location? See all MSK locations.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Boardman
- A Phase 1 Study of CAR T Cell Therapy for People with HIV and B Cell Lymphoma

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Boardman’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
4.9 149 reviews
- 4.9 Provider's Explanations Easy to Understand
- 4.9 Trusts Provider with Care
- 4.9 Provider Listened Carefully
- 4.9 Likelihood of Recommending Provider
Every visit to MSK has been professional and the staff has always been kind and caring. Dr. Boardman is amazing .
I have peace-of-mind knowing Dr. Boardman is in charge of my care.
Dr. Boardman is the most compassionate, knowledgeable, and empathetic physician I have encountered during my cancer journey. I travel across the country two to three times a year to see him. His level of knowledge and conviction are at the highest possible level. I recommend Dr. Boardman to all who are in need of his care.
I am being treated by the BEST in the world
Dr. Boardman was patient, kind, and reassuring. There are not enough ways to describe how happy I am with my care up to this point.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Alexander P. Boardman discloses the following relationships and financial interests:
-
Bristol-Myers Squibb
Professional Services and Activities -
Cancer Study Group, LLC
Professional Services and Activities
-
OncLive
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.